首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1535578

生物光子市場 - 按技術（體外、體內）、按應用（透視成像、顯微鏡、內部成像、光譜分子、分析感測、光療法、表面成像、生物感測器）、按最終用途和預測，2024 年- 2032

Biophotonics Market - By Technology (In-vitro, In-vivo), By Application (See-through Imaging, Microscopy, Inside Imaging, Spectro Molecular, Analytics Sensing, Light Therapy, Surface Imaging, Biosensors), By End Use & Forecast, 2024 - 2032

出版日期: 2024年06月04日 | 出版商:

Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於對非侵入性診斷的需求不斷增加和醫療保健支出不斷增加，2024年至2032年全球生物光子市場規模的複合年成長率將達到10.9%。非侵入性診斷方法，例如先進的影像和光療法，為患者和提供者提供侵入性較小的選擇，恢復時間更快，舒適度更高。此外，不斷成長的醫療保健預算使得對尖端技術和創新解決方案的投資成為可能。對非侵入性技術的需求增加和醫療進步的財政資源增加相結合，促進了生物光子產業的大幅成長，支持其擴張和發展。

例如，2024 年 3 月，BioPhotas, Inc. 推出了 Celluma CONTOUR，這是一款經 FDA 批准的光治療設備，用於身體輪廓、皮膚老化和疼痛管理，標誌著光治療的重大進步。 FDA 對該設備的批准突顯了生物光子學應用的監管支持和驗證不斷增加。這項進展反映了將光療法融入主流醫療實踐的更廣泛趨勢，可能推動市場擴張並鼓勵對生物光子技術的進一步投資和研究。

生物光子市場根據技術、應用、最終用途和地區進行分類。

由於醫療診斷領域在提高診斷準確性和效率方面發揮著至關重要的作用，因此到 2032 年，醫療診斷領域將顯著擴張。光學成像和螢光技術等生物光子技術的進步顯著改善了疾病檢測和監測。對早期精確診斷工具不斷成長的需求推動了採用，因為這些技術提供了非侵入性和高度敏感的解決方案。此外，增加對創新診斷應用的研發投資進一步鞏固了該領域在生物光子產業的主導地位。

到 2032 年，光療領域將獲得可觀的收益，這歸因於其在治療一系列醫療狀況和改善患者治療效果方面的應用不斷成長。光療技術的進步為疼痛管理、皮膚病和情緒障礙提供了非侵入性、有效的解決方案。人們越來越認知到光治療的好處，加上對替代和補充療法的需求不斷成長，推動了這一領域的大幅成長。治療應用範圍的擴大和技術創新進一步鞏固了其在市場上的地位。

在其強大的醫療基礎設施、先進的研究能力和對醫療創新的高度重視的推動下，歐洲生物光子市場佔有率將在 2024 年和 2032 年達到顯著的複合年成長率。該地區對生物光子學研究和開發的廣泛投資，加上政府的支持性政策以及對先進診斷和治療解決方案不斷成長的需求，推動了市場的顯著成長。歐洲已建立的領先學術和研究機構網路，以及積極整合尖端技術的方法，使其成為生物光子產業的顯著貢獻者。

產業生態系統分析
供應商矩陣
利潤率分析
技術與創新格局
專利分析
重要新聞和舉措
監管環境
衝擊力
- 成長動力
  - 技術進步
  - 對非侵入性診斷技術的需求不斷成長
  - 增加生命科學領域的應用
  - 政府措施和資金
  - 個人化醫療需求不斷成長
- 產業陷阱與挑戰
  - 技術成本高
  - 複雜的監管環境
成長潛力分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：依技術分類，2021 - 2032 年

體外
體內

第 6 章：市場估計與預測：依應用分類，2021 - 2032

透視成像
顯微鏡檢查
內部影像
光譜分子
分析感測
光療
表面成像
生物感測器

第 7 章：市場估計與預測：依最終用途，2021 - 2032 年

測試和組件
醫學治療
醫療診斷
非醫療應用

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳新銀行
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
MEA
- 阿拉伯聯合大公國
- 南非
- 沙烏地阿拉伯
- MEA 的其餘部分

第 9 章：公司簡介

Affymetrix Inc. (Thermo Fisher Scientific Inc.)
Becton, Dickinson and Company
Carl Zeiss AG
Glenbrook Technologies
Hamamatsu Photonics K.K
IDEX
IPG Photonics Corporation
NU Skin Enterprises
Olympus Corporation
Oxford Instruments PLC
PerkinElmer Inc.
Thermo Fisher Scientific
TOSHIBA CORPORATION
Zecotek Photonics Inc.
ZEISS Group
Zenalux Biomedical Inc.

簡介目錄

Product Code: 9733

Global Biophotonics Market size will register a 10.9% CAGR from 2024 to 2032, owing to the increasing demand for non-invasive diagnostics and rising healthcare spending. Non-invasive diagnostic methods, such as advanced imaging and light-based therapies, offer patients and providers less intrusive options with faster recovery times and improved comfort. Also, growing healthcare budgets enable investment in cutting-edge technologies and innovative solutions. This combination of heightened demand for non-invasive techniques and increased financial resources for medical advancements fosters substantial growth in the biophotonics industry, supporting its expansion and development.

For instance, in March 2024, BioPhotas, Inc. introduced the Celluma CONTOUR, an FDA-cleared light therapy device for body contouring, aging skin, and pain management, marking a significant advancement in light-based treatments. The FDA clearance of this device underscores the increasing regulatory support and validation for biophotonics applications. This advancement reflects a broader trend of integrating light therapy into mainstream medical practices, potentially driving market expansion and encouraging further investment and research in biophotonics technologies.

The biophotonics market is divided based on technology, application, end-use, and region.

The medical diagnostics segment will witness remarkable expansion through 2032 due to its crucial role in enhancing diagnostic accuracy and efficiency. Advances in biophotonics technologies, such as optical imaging and fluorescence-based techniques, significantly improve disease detection and monitoring. The growing demand for early and precise diagnostic tools drives adoption, as these technologies offer non-invasive and highly sensitive solutions. Additionally, increasing investments in research and development for innovative diagnostic applications further bolster the segment's dominance in the biophotonics industry.

The light therapy segment will garner considerable gains by 2032, attributed to its growing application in treating a range of medical conditions and improving patient outcomes. Advances in light therapy technologies offer non-invasive, effective solutions for pain management, skin disorders, and mood disorders. The increasing awareness of the benefits of light-based treatments, coupled with rising demand for alternative and complementary therapies, drives substantial growth in this segment. The expanding range of therapeutic applications and technological innovations further solidify its position in the market.

Europe biophotonics market share will reach a noteworthy CAGR during 2024 and 2032, propelled by its robust healthcare infrastructure, advanced research capabilities, and a strong emphasis on medical innovation. The region's extensive investment in biophotonics research and development, coupled with supportive government policies and a growing demand for advanced diagnostic and therapeutic solutions, drives significant market growth. Europe's established network of leading academic and research institutions, along with its proactive approach to integrating cutting-edge technologies, makes it a notable contributor to the biophotonics industry.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360º synopsis, 2021 - 2032

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Vendor matrix
3.3 Profit margin analysis
3.4 Technology & innovation landscape
3.5 Patent analysis
3.6 Key news and initiatives
3.7 Regulatory landscape
3.8 Impact forces
- 3.8.1 Growth drivers
  - 3.8.1.1 Advancements in technology
  - 3.8.1.2 Rising demand for non-invasive diagnostic techniques
  - 3.8.1.3 Increasing applications in life sciences
  - 3.8.1.4 Government initiatives and funding
  - 3.8.1.5 Rising demand for personalized medicine
- 3.8.2 Industry pitfalls & challenges
  - 3.8.2.1 High cost of technology
  - 3.8.2.2 Complex regulatory environment
3.9 Growth potential analysis
3.10 Porter's analysis
- 3.10.1 Supplier power
- 3.10.2 Buyer power
- 3.10.3 Threat of new entrants
- 3.10.4 Threat of substitutes
- 3.10.5 Industry rivalry
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Technology, 2021 - 2032 (USD Billion)

5.1 In-vitro
5.2 In-vivo

Chapter 6 Market Estimates & Forecast, By Application, 2021 - 2032 (USD Billion)

6.1 See-through imaging
6.2 Microscopy
6.3 Inside imaging
6.4 Spectro molecular
6.5 Analytics sensing
6.6 Light therapy
6.7 Surface imaging
6.8 Biosensors

Chapter 7 Market Estimates & Forecast, By End Use, 2021 - 2032 (USD Billion)

7.1 Tests and components
7.2 Medical therapeutics
7.3 Medical diagnostics
7.4 Non-medical application

Chapter 8 Market Estimates & Forecast, By Region, 2021 - 2032 (USD Billion)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 UK
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 ANZ
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 MEA
- 8.6.1 UAE
- 8.6.2 South Africa
- 8.6.3 Saudi Arabia
- 8.6.4 Rest of MEA